ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,255,031 | +3.0% | 11,576,537 | +18.3% | 5.09% | +14.1% |
| Q2 2023 | $234,308,814 | +51.0% | 9,783,249 | +18.7% | 4.46% | +38.1% |
| Q1 2023 | $155,130,700 | +165.4% | 8,242,864 | +124.5% | 3.23% | +170.7% |
| Q4 2022 | $58,441,333 | -2.7% | 3,670,938 | 0.0% | 1.19% | -13.9% |
| Q3 2022 | $60,057,000 | +0.9% | 3,670,938 | -13.1% | 1.38% | -9.9% |
| Q2 2022 | $59,518,000 | – | 4,224,109 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |